iifl-logo-icon 1

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

sidebar image

CortiqaHealth, an Enterprise Wellness Platform, Secures Angel Funding

28 Jul 2022 , 06:42 PM

Business Wire India

CortiqaHealth announces securing Angel investment from a group of marquee US investors, together with seed funding from founding members. CortiqaHealth would be raising a bridge round in the next quarter, to support the Product Validation and Go-to-Market efforts.
 
CortiqaHealth’s mission is to create a healthier community and aims to achieve it by democratizing wellness with computer vision and deep learning. It has secured an Angel investment of USD 1 Million from a group of marquee US investors.
 
In current times, lack of awareness on wellness, low priority of healthcare, limited access to diagnostics, high dependency on healthcare workforce for health assessments, the urban rural healthcare divide, affordability gap, inconsistent monitoring of wellness and lack of a holistic view on wellness have been further exacerbated by the recent pandemic. With emphasis on technology, integration of human expertise and passion for wellness, a group of serial entrepreneurs, unicorn executives, private equity professionals, healthcare IT, wellness, and manufacturing executives, have come together to create CoHeal (www.coheal.ai).
 
CoHeal is a non-invasive, quantitative point of care testing platform using smartphones.
 
“CortiqaHealth’ s team of talented professionals are on a mission to enable accessible, affordable care,” says Richard Atkin, Healthcare Industry Veteran and Key Investor in CortiqaHealth. Adding on, Atkin further emphasizes, “Their innovative CoHeal platform will transform health, wellness and care for underserved communities.”
 
Bhaskar Appacudal, Healthcare IT Executive, Founding Member and Chief Architect at CortiqaHealth, says, “With emphasis on the pre-ambulatory segment, CoHeal is democratizing wellness and empowering users by enabling early access to their wellness data.”


About CortiqaHealth Pvt. Ltd.

CortiqaHealth is building CoHeal, an Enterprise Wellness platform aimed at being a key enabler to healthier lifestyles, by making wellness accessible, affordable, and easy to use.

For more information, visit: www.coheal.ai

About Richard Atkin

Richard Atkin is currently Executive Chairman of the Board at Greenway Health. Richard has over 30 years of experience as an executive for healthcare, technology, and software companies, and serves as an operating principal at Vista Equity Partners. At this capacity, Richard served on the boards of numerous Vista companies, partnering with CEOs to charter their companies’ strategies and growth. He previously served as the president of Vista Consulting Group. Prior to joining VCG, Richard was CEO of Sunquest Information Systems Inc., a market leading provider of hospital laboratory information systems. Richard holds a Bachelor of Science degree in Physics and Electronic Materials from Bangor University and a Master of Business Administration from Imperial College, London.
 
About Bhaskar Appacudal

With over 3 decades of IT Industry experience, Bhaskar Appacudal was associated with Vista for over 16 years and most recently as Managing Director of APAC overseeing the creation of CoEs for Vista portfolio companies. Prior to this role, Bhaskar was CTO at Aptean, responsible for overseeing the global development of Aptean products. Bhaskar was also the CTO at Sunquest, heading the Global Innovation Center of Excellence. Bhaskar set up and managed the offshore software development activities for Apple in India. Prior to Apple, as part of his assignment at IBM, Bhaskar has worked in the U.S, Australia, Singapore, and Indonesia. Bhaskar holds a Bachelor of Engineering degree in Electronics and Communications from PSG Tech, and a Master of Science in Computer Engineering from Michigan Tech, Michigan, USA.

Related Tags

  • Advertising
  • Business Services
  • Consumer interest
  • Education & Training
  • Financial Analyst & Investors
  • General
  • Healthcare & biotechnology
sidebar mobile

BLOGS AND PERSONAL FINANCE

Read More
Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.